Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Benzinga Rankings give you vital metrics on any stock – anytime.
Explore Autolus Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for AUTL.
You can purchase shares of Autolus Therapeutics (NASDAQ:AUTL) through any online brokerage.
Other companies in Autolus Therapeutics’s space includes: Tectonic Therapeutic (NASDAQ:TECX), Humacyte (NASDAQ:HUMA), Precigen (NASDAQ:PGEN), Upstream Bio (NASDAQ:UPB) and Altimmune (NASDAQ:ALT).
Autolus Therapeutics has a consensus price target of $9.27.
The stock price for Autolus Therapeutics (NASDAQ: AUTL) is $1.72 last updated March 21, 2025 at 6:59 PM EDT.
There are no upcoming dividends for Autolus Therapeutics.
Autolus Therapeutics’s Q1 earnings are confirmed for Tuesday, May 13, 2025.
There is no upcoming split for Autolus Therapeutics.
Autolus Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.